Venture capital deal documents for a priced round are a mostly non-binding term sheet plus five definitive agreements: the stock purchase agreement (SPA), the restated charter, the investors' rights agreement (IRA), the voting agreement, and the right of first refusal and co-sale agreement (ROFR). In the US, those five usually start from National Venture Capital Association (NVCA) model forms.
The term sheet gets the attention. The other five run your company for years.
This guide explains what each document controls, which terms are worth negotiating, what changed in the NVCA models in 2025 and 2026, and what a realistic timeline and legal bill look like.
Why venture capital deal documents are standardized
The NVCA model documents give lawyers on both sides a common starting point, so negotiation can focus on the handful of business terms that matter instead of on boilerplate. Cooley GO calls them an industry standard for US venture financings whose widespread adoption has reduced friction in closing deals, and NVCA publishes them free. Learn the structure once and most of that knowledge carries into later rounds.
NVCA's current model set covers the five definitive agreements plus supporting forms such as a management rights letter and an indemnification agreement. It doesn't currently include a model term sheet for venture financings, so term sheet formats vary more from investor to investor than the definitive documents do.
Here's the catch. "Standard" doesn't mean "founder-friendly." Model documents are full of bracketed options, and which option gets picked is a negotiation. Knowing what each document does tells you which brackets are worth a fight.
If you're raising on SAFEs, most of this doesn't apply yet. A SAFE is a single short document, and the priced-round set arrives with your first equity round. See SAFE vs priced round for that decision.
What changed in the NVCA model documents in 2025 and 2026
The models are kept current, so check which version your counsel is using:
- October 2025. NVCA released updates to five documents: the certificate of incorporation, SPA, IRA, voting agreement and ROFR and co-sale agreement. NVCA said the changes address evolving market norms, recent legal developments including the Outbound Investment Security Program and bulk data rules, and tranched financing mechanics.
- What that means in the SPA. Per Foley & Lardner's summary, the SPA now formally addresses milestone-based ("tranched") financings, adds representations reflecting US national security and data security oversight, and reflects the 2025 QSBS changes, including the $75 million gross asset test.
- What that means in the IRA. Foley & Lardner notes the IRA now encourages companies to adopt NVCA's suite of governance policies.
- 2026 revisions. NVCA's model documents page now lists the ROFR and co-sale agreement as updated in April 2026 and the voting agreement as updated in June 2026. The page doesn't summarize those changes, so ask your lawyer what moved.
If you accept a tranched round, push for objective, verifiable milestones. A missed tranche can leave you short of runway at exactly the wrong moment.
The six core venture capital deal documents
Document 1: The term sheet
What it is. A short summary of the deal, often a handful of pages, and mostly non-binding. It sets valuation, round size, the type of preferred stock, board composition, protective provisions, liquidation preference, anti-dilution, the option pool and founder vesting.
It usually also contains binding clauses on confidentiality and a "no-shop" exclusivity period. Cooley GO notes that exclusivity is often the only binding part of a term sheet and suggests 30 to 45 days is plenty of time to finalize a venture investment; the length varies by deal.
Why it matters. Most of what goes into the later documents is decided here. Changing an economic term after signing is possible, but it costs goodwill. Negotiate now.
What to focus on. Pre-money valuation and whether the option pool increase is counted in it; liquidation preference; board seats; protective provisions; anti-dilution (broad-based weighted average is common, while full ratchet is widely seen as a red flag); and any reset of founder vesting. The full walkthrough is in term sheets for startup founders.
What market terms look like. Cooley's Q2 2026 Venture Financing Report, covering 166 financings the firm handled, found that 95.8% of deals had a 1x liquidation preference and 96.4% used non-participating preferred stock. If a term sheet departs from that, ask why.
Document 2: The stock purchase agreement (SPA)
What it is. The contract in which investors buy shares. It states the price and number of shares, the closing mechanics and, most importantly, the company's representations and warranties: statements about the business (the cap table is accurate, there is no undisclosed litigation, IP is assigned, taxes are paid).
Why it matters. Reps and warranties are qualified by a disclosure schedule, where exceptions to the reps are listed. A misstatement, even by omission, can create exposure and give investors remedies later.
What to negotiate. Knowledge qualifiers ("to the company's knowledge") on reps you can't verify absolutely; the scope of the disclosure schedule; and whether founders give any reps personally (many founders push back on this at seed). Check the closing conditions too, which can require signed IP assignments from every employee and contractor.
Practical tip. A disclosure schedule is only as good as the records behind it. A messy cap table or missing contractor agreements surface here and slow the deal. It's the same reason we push founders toward an organized seed deal room well before anyone asks for one.
Document 3: The amended and restated certificate of incorporation (the charter)
What it is. The document filed with the state (Delaware for most venture-backed companies) that creates the new series of preferred stock and defines its rights: liquidation preference, conversion, dividends, anti-dilution and the protective provisions that require preferred approval for certain actions.
Why it matters. Because it is filed with the state and binds the company itself, the charter is generally the hardest document to change later. Future rounds typically amend it.
What to watch.
- Liquidation preference. 1x non-participating means investors take their money back or convert to common, whichever is worth more. Participating preferred means they take their money back and then share in the rest, which can sharply reduce founder proceeds in a mid-size exit. The liquidation preference guide shows the math.
- Protective provisions. Actions the company can't take without preferred approval: selling the company, issuing senior stock, amending the charter, taking on debt above a threshold, changing board size. Aim for a short list with sensible thresholds.
- Anti-dilution. Broad-based weighted average is common. Full ratchet is unusual at early stage, and we'd resist it.
Document 4: The investors' rights agreement (IRA)
What it is. The contract that gives investors ongoing rights after closing: information rights (financial statements and budgets on a schedule), registration rights (rights tied to a future IPO, rarely relevant early but usually included), and pro rata rights (the right to buy into future rounds to maintain ownership).
Why it matters. Information rights define what you send investors every month or quarter. Pro rata rights shape who can join your next round, and they can crowd out new investors if too many holders have them.
What to negotiate. A "major investor" threshold, so only investors above a set check size get full information and pro rata rights; reasonable reporting deadlines (Nixon Peabody's summary of the NVCA form describes quarterly statements within 45 days and annual statements within 90 to 120 days); and whether pro rata rights fall away if an investor skips a round.
Some IRAs also include covenants such as maintaining D&O insurance or requiring standard vesting on option grants, and the October 2025 NVCA version encourages companies to adopt governance policies.
Document 5: The voting agreement
What it is. The agreement among stockholders that sets how the board is elected and usually contains a drag-along provision.
Why it matters. Board composition is a big part of control. Seed boards are often three seats (for example, two founders and one investor, or one founder, one investor and one independent), and Series A boards are often five (for example, two founders, two investors and one independent), though structures vary. The voting agreement locks in who elects whom.
The drag-along requires all stockholders to support a sale if a defined group (often the board plus a majority of preferred, and ideally a majority of common) approves it. It exists so a small holder can't block an exit; see drag-along rights for the details.
What to negotiate. Who counts toward the drag-along trigger (founders often ask that common holders, meaning you, be part of it); how the independent director is chosen; and whether investor board seats fall away below an ownership threshold.
Document 6: The right of first refusal and co-sale agreement (ROFR)
What it is. Restrictions on founders and other key common holders selling shares. The company, then the investors, get the first right to buy shares a founder wants to sell (ROFR). If they pass, investors can sell alongside the founder on the same terms (co-sale, or tag-along).
Why it matters. It limits founder liquidity, which is largely the point from the investor's view, and keeps shares from landing with unknown buyers.
What to negotiate. Carve-outs for estate-planning transfers and small sales; a threshold below which the ROFR doesn't apply; and symmetry (if founders are restricted, some argue investor transfers to non-affiliates should be too).
Supporting documents you will also sign
- Board and stockholder consents approving the round.
- Management rights letter for certain institutional investors, which need it for regulatory reasons.
- Indemnification agreements for new directors.
- Updated equity plan if the option pool is increasing.
- Side letters for specific investors, which we'd keep to a minimum.
"They're standard forms. Why sweat them?"
It's a reasonable instinct. The NVCA models exist precisely so nobody has to reinvent them, and a founder who fights every clause burns legal fees and goodwill for little gain. Most of the boilerplate really is fine.
But.
The fights that matter are small in number and large in consequence: participation, protective provisions, the drag-along trigger, who picks the independent. They sit inside the "standard" documents as bracketed choices. Skim past them and you have made a decision without noticing.
Closing timeline and legal cost expectations
Rough, illustrative ranges for a seed or Series A priced round (every deal differs, and the middle phases often overlap):
| Phase | Typical duration |
|---|---|
| Term sheet negotiation | 3 to 10 days |
| Diligence and drafting | 2 to 4 weeks |
| Document negotiation | 1 to 3 weeks |
| Signing and wire | 1 to 5 days |
From signed term sheet to money in the bank, about 3 to 6 weeks is a common target, in line with Cooley GO's view that 30 to 45 days is plenty of time to finalize a venture investment. Faster closes tend to happen when both sides stick to model forms and the data room is ready. Much longer usually means diligence found a problem.
Legal fees vary widely by firm, city and complexity, and Series A bills generally run higher than seed. Ask company counsel for a fixed-fee or capped estimate before you start. In many priced rounds the company also agrees to pay the lead investor's legal fees; if your term sheet includes that, a dollar cap is a common ask.
Three things that often shorten the timeline and reduce cost:
- A clean, current data room before the term sheet is signed (our data room checklist lists what to include by stage).
- A lawyer who does venture deals every week, not occasionally.
- Staying close to model forms and negotiating business terms rather than boilerplate.
Founders who have run a real sales process often find closing familiar: stakeholders, a checklist and a deadline. 1752vc's Accelerate program pairs its $100K investment (at a valuation cap of up to $3.5M) with founder-led go-to-market and sales training and access to a network of 850+ investors, which helps founders build the traction and investor relationships that lead to a priced round.
The bottom line
Spend your negotiating energy on the term sheet and the handful of brackets that carry economics and control. Let the boilerplate be boilerplate.
The wire is the celebration.
The documents are the marriage.
Key takeaways
- A priced venture round uses six core documents: term sheet, SPA, charter, IRA, voting agreement and ROFR, with the definitive documents usually based on NVCA models.
- NVCA updated five model documents in October 2025, adding tranched-financing mechanics and national security representations, and revised the ROFR (April 2026) and voting agreement (June 2026) again this year.
- The term sheet decides most of the deal, so in our view it is the place to negotiate economics and control.
- Cooley's Q2 2026 data shows 1x non-participating preferred is the prevailing market norm in its sample.
- Roughly 3 to 6 weeks from term sheet to wire is common, and a cap on the investor counsel fees you pay is worth negotiating.
Frequently asked questions
A priced round typically involves a term sheet, a stock purchase agreement, an amended and restated certificate of incorporation, an investors' rights agreement, a voting agreement, and a right of first refusal and co-sale agreement, plus board and stockholder consents. In the US, the definitive documents are usually based on the NVCA models.
Each side has its own counsel. The company pays its own lawyers, and in many priced rounds it also agrees to cover the lead investor's legal fees up to a negotiated cap. Fees vary widely by firm, city and deal complexity, so a fixed-fee or capped estimate and staying close to the model forms can help limit billable negotiation.
The stock purchase agreement is the one-time contract for buying the shares, covering price, closing mechanics and the company's representations and warranties. The investors' rights agreement governs the relationship after closing, including information rights, pro rata rights and registration rights. In short, the SPA closes the deal and the IRA runs for years afterward.
They are free template financing documents published by the National Venture Capital Association, covering the stock purchase agreement, certificate of incorporation, investors' rights agreement, voting agreement, and ROFR and co-sale agreement, plus supporting forms. NVCA updated five of them in October 2025 and revised the ROFR and voting agreement again in 2026.
From signed term sheet to funds wired, about 3 to 6 weeks is common for a seed or Series A priced round. A ready data room, experienced counsel and model forms can make it faster, while diligence problems can push it well past two months.
Sources
- NVCA: Model Legal Documents
- NVCA: NVCA Releases 2025 Updates to Model Legal Documents
- Foley & Lardner: Breaking Down the October 2, 2025 NVCA Updates to the Model Legal Documents
- Cooley: Q2 2026 Venture Financing Report
- Cooley GO: Negotiating Term Sheets
- Cooley GO: NVCA Financing Documents
- Nixon Peabody: Understanding the Investor Rights Agreement
Disclaimer: This guide is for general education only and is not legal, tax or investment advice. Laws, market data and program terms change, so it may not reflect the latest developments or fit your situation. Treat it as a starting point, not a source of truth, and talk to a qualified lawyer, accountant or financial adviser before you make decisions.
